UA93404C2 - Фармацевтическая композиция для орального введения суспензированного комплекса четырехвалентной платины - Google Patents

Фармацевтическая композиция для орального введения суспензированного комплекса четырехвалентной платины

Info

Publication number
UA93404C2
UA93404C2 UAA200814645A UAA200814645A UA93404C2 UA 93404 C2 UA93404 C2 UA 93404C2 UA A200814645 A UAA200814645 A UA A200814645A UA A200814645 A UAA200814645 A UA A200814645A UA 93404 C2 UA93404 C2 UA 93404C2
Authority
UA
Ukraine
Prior art keywords
suspension
independently
carbon atoms
another
platinum complex
Prior art date
Application number
UAA200814645A
Other languages
English (en)
Ukrainian (uk)
Inventor
Алес Франк
Петр Сова
Original Assignee
Плива-Лахема A.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Плива-Лахема A.C. filed Critical Плива-Лахема A.C.
Publication of UA93404C2 publication Critical patent/UA93404C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Оральная фармацевтическая композиция, которая состоит из суспензии комплекса платины общей формулы II,, (II)в по крайней мере одном фармацевтически приемлемом растительном, животном, минеральном, синтетическом или полусинтетическом масле и/или маслянистом веществе, в котором содержимое комплекса платины составляет от 0,5 до 50 % по весу от общего веса композиции и по крайней мере один фармацевтически приемлемый наполнитель.
UAA200814645A 2006-06-20 2007-06-20 Фармацевтическая композиция для орального введения суспензированного комплекса четырехвалентной платины UA93404C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CZ20060402A CZ300424B6 (cs) 2006-06-20 2006-06-20 Farmaceutická kompozice pro perorální podání

Publications (1)

Publication Number Publication Date
UA93404C2 true UA93404C2 (ru) 2011-02-10

Family

ID=38819283

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200814645A UA93404C2 (ru) 2006-06-20 2007-06-20 Фармацевтическая композиция для орального введения суспензированного комплекса четырехвалентной платины

Country Status (18)

Country Link
US (1) US7767709B2 (ru)
EP (1) EP2034957B1 (ru)
JP (1) JP2009541227A (ru)
KR (1) KR20090048436A (ru)
CN (1) CN101505727A (ru)
AT (1) ATE478655T1 (ru)
AU (1) AU2007262493A1 (ru)
CZ (1) CZ300424B6 (ru)
DE (1) DE602007008724D1 (ru)
DK (1) DK2034957T3 (ru)
ES (1) ES2358205T3 (ru)
IL (1) IL196100A0 (ru)
PL (1) PL2034957T3 (ru)
PT (1) PT2034957E (ru)
RU (1) RU2430718C2 (ru)
SI (1) SI2034957T1 (ru)
UA (1) UA93404C2 (ru)
WO (1) WO2007147371A2 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ296459B6 (cs) * 2004-09-14 2006-03-15 Pliva-Lachema A. S. Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
BR112014029131B1 (pt) * 2012-05-31 2021-03-09 Allergan Pharmaceuticals International Limited cápsula de mucoadesivo
SG11201804885TA (en) 2015-12-09 2018-07-30 Univ Wien Med Monomaleimide-functionalized platinum compounds for cancer therapy

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8328218D0 (en) * 1983-10-21 1983-11-23 Johnson Matthey Plc Oral compositions
ES2063119T3 (es) * 1988-02-02 1995-01-01 Johnson Matthey Inc Complejos de pt (iv).
JPH02290813A (ja) * 1989-04-28 1990-11-30 Sumitomo Pharmaceut Co Ltd ヨード化油および脂溶性白金（２）錯体からなる制癌組成物
FI905018A0 (fi) * 1989-10-17 1990-10-12 Bristol Myers Squibb Co I vatten och loesningsmedel loesliga axiala hydroxi-och mono- och dikarboxylsyraderivat med stor tumoeraktivitet.
US5656290A (en) * 1993-02-26 1997-08-12 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
AU4842996A (en) * 1995-02-28 1996-09-18 Yoshinori Kidani Novel platinum (iv) complexes, process for producing the same, and carcinostatic agents containing the same
US5736151A (en) * 1996-12-09 1998-04-07 Pharmacia & Upjohn Company Antibiotic oil suspensions
IL131008A (en) * 1997-02-05 2003-06-24 Upjohn Co Lipid complexes and liposomes of highly insoluble platinum complex dicarboxylate
JPH10265380A (ja) * 1997-03-17 1998-10-06 Bristol Myers Squibb Co 抗ガン剤
KR100246722B1 (ko) * 1997-12-30 2000-04-01 박호군 경구용 백금 착화합물 항암제 및 그 제조방법
CZ288912B6 (cs) * 1998-05-27 2001-09-12 Lachema, A. S. Komplex platiny v oxidačním čísle IV, způsob přípravy tohoto komplexu, tento komplex jako léčivo a farmaceutická kompozice tento komplex obsahující
PE20001227A1 (es) * 1998-10-30 2000-11-06 Hoffmann La Roche Procesos para producir una composicion de isotretinoina
US7253209B2 (en) * 2000-08-11 2007-08-07 Dainippon Sumitomo Pharma Co., Ltd. Remedies for cisplatin-tolerant cancer
US20030082102A1 (en) * 2001-06-25 2003-05-01 Court Wayne S. Radioactive platinum complexes for cancer treatment
US20030059375A1 (en) * 2001-08-20 2003-03-27 Transave, Inc. Method for treating lung cancers
US20040170677A1 (en) * 2002-11-26 2004-09-02 Ning Hu Method of drug loading in liposomes by gradient
CZ295584B6 (cs) * 2004-02-12 2005-08-17 Pliva-Lachema A. S. Farmaceutická kompozice obsahující jako účinnou látku platinový komplex a způsob výroby této kompozice
CZ296045B6 (cs) * 2003-03-31 2005-12-14 Pliva-Lachema A. S. Farmaceutická kompozice obsahující jako účinnou látku komplex čtyřmocné platiny a způsob její výroby
MX2007004955A (es) * 2004-11-08 2007-06-14 Transave Inc Metodo de tratar cancer con formulaciones de compeusto de platino a base de lipido administradas intraperitonealmente.
ATE431140T1 (de) * 2005-03-11 2009-05-15 Gpc Biotech Ag Antiproliferative kombinations-therapie mit satraplatin oder jm118 und docetaxel
EP1792622A1 (en) * 2005-11-11 2007-06-06 GPC Biotech AG Anti-proliferative combination therapy comprising a platinum-based chemotherapeutic agent and EGFR inhibitors or pyrimidine analogues
CZ300120B6 (cs) * 2006-06-20 2009-02-11 Pliva - Lachema A. S. Farmaceutická kompozice pro injekcní podání
CZ300590B6 (cs) * 2006-06-20 2009-06-24 Pliva - Lachema A. S. Farmaceutická kompozice pro injekcní podání

Also Published As

Publication number Publication date
RU2009101498A (ru) 2010-07-27
DE602007008724D1 (de) 2010-10-07
WO2007147371A2 (en) 2007-12-27
US20100010083A1 (en) 2010-01-14
EP2034957B1 (en) 2010-08-25
PL2034957T3 (pl) 2011-04-29
DK2034957T3 (da) 2010-12-20
EP2034957A2 (en) 2009-03-18
KR20090048436A (ko) 2009-05-13
US7767709B2 (en) 2010-08-03
WO2007147371B1 (en) 2008-06-19
WO2007147371A3 (en) 2008-04-17
JP2009541227A (ja) 2009-11-26
CZ300424B6 (cs) 2009-05-13
ES2358205T3 (es) 2011-05-06
PT2034957E (pt) 2010-11-30
RU2430718C2 (ru) 2011-10-10
IL196100A0 (en) 2009-09-01
CN101505727A (zh) 2009-08-12
ATE478655T1 (de) 2010-09-15
CZ2006402A3 (cs) 2007-12-27
SI2034957T1 (sl) 2011-03-31
AU2007262493A1 (en) 2007-12-27

Similar Documents

Publication Publication Date Title
MY148429A (en) Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
MY139302A (en) Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
CY1109457T1 (el) Παραγωγο aminoαλκοολης ή παραγωγο φωσφονικου οξεος και φαρμακευτικη συνθεση που τα περιεχει
UA102517C2 (ru) Замещенные производные морфолина и тиоморфолина, фармацевтическая композиция на их основе и их применение для производства лекарственного средства для лечения расстройства или заболевания центральной нервной системы
MY143565A (en) Novel fluorocglycoside derivatives of pyrazoles: medicaments containing these compounds, and the use thereof
BR0309528A (pt) Comprimido com alta carga de droga
TW200626158A (en) Naphthaline derivatives
TW200637817A (en) 5-aminoindole derivatives
MX2007006387A (es) Derivados de piridina 3-substituidos como antagonistas h3.
MX2007007027A (es) Derivados piperazinilpiridina como agentes anti-obesidad.
MX2010002191A (es) Composiciones y metodos que emplean antagonistas nmda para lograr un efecto anestesico limitado.
HUT75513A (en) Taxane class derivative based pharmaceutical compositions and their preparation
TN2009000483A1 (fr) Derives de 7-alkynyl-1-8-naphthyridones, leur preparation et leur application en therapeutique
ATE491445T1 (de) Orale pharmazeutische zusammensetzung für den gezielten transport eines platinkomplexes in den kolorektalbereich, verfahren zu ihrer herstellung und verwendung als medikament
MA29653B1 (fr) Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MA31142B1 (fr) Derives heteroaryles de pyrrolidinyl et piperdinyl cetones.
IL164440A0 (en) New pharmaceutical composition containing fibanserin polymorph a
UA93404C2 (ru) Фармацевтическая композиция для орального введения суспензированного комплекса четырехвалентной платины
UA93405C2 (ru) Фармацевтическая композиция для инъекционного введения, которая содержит соединение четырехвалентной платины
UA93715C2 (ru) Фармацевтическая композиция для инъекционного введения ha ochobe соединения четырехвалентной платины и циклодекстрина
MX2009005242A (es) Derivados de 3-(hetero)arilisoquinolinamida sustituida en posición 5, 6 o 7 y uso terapeutico del mismo.
ATE448223T1 (de) 8-azabicycloä3.2.1üoctanderivate und ihre verwendung als monoamine-neurotransmitter- reuptake inhibitoren
BRPI0414644A (pt) composto, composições farmacêuticas, e, uso de um composto
WO2007000662A3 (en) Novel propofol composition comprising ascorbic acid or pharmaceutically acceptable salts thereof
PL1732902T3 (pl) Pochodne nukleozydów i ich terapeutyczne zastosowanie